Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction - REVEAL

Description:

The goal of the trial was to evaluate treatment with erythropoietin compared with placebo after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).